Dr Minal Mohit - Managing Diabetes Using New Molecules Like GLP1 RAs
Dr Minal Mohit MBBS, MD - General Medicine, FRCP - Endocrinology. She is a General Physician, diabetes, thyroid and endocrine disorder specialist in Jaipur with over 10 yrs of experience. She shares her view on managing diabetes by targeting obesity using molecules like GLP1 RAs. The first in the line is Exenatide followed by Liraglutide, Dulaglutide and Semaglutide.
Dr Jitendra Patel - Benefits of Oral GLP-1 Analogue Semaglutide
Dr Jitendra Patel, MBBS, MD - Medicine, Consultant Physician, diabetologist and cardiologist at Pruthvi hospital for last 23 yrs. He discusses the benefits of new molecules in the field of diabetes, oral GLP-1 analogue semaglutide, in HbA1c reduction, bodyweight loss, pleiotropic effects, lipid management, and hypertension.
Dr DeFronzo with Dr. Akshay Jain - GLP-1 analogs for diabetes management
Dr DeFronzo, a known researcher & endocrinologist, is credited with development of metformin and dapagliflozin. His interests focus on the pathogenesis and treatment of T2DM and Insulin Resistance Syndrome. He summarizes GLP-1 analog benefits: reduces A1C levels, preserves beta-cell function, no risk of hypoglycemia, weight loss, safety profile with cardioprotection.
